These Two Companies Keep Raising Their Dividends at a Rapid Pace, and Long-Term Investors Could Reap Higher Returns Oct 14, 2026 Financial Service, Life Science
UnitedHealth Tops Q3 Estimates, Raises 2026 Outlook Again — Is the Worst Over? Oct 13, 2026 Financial Service, Life Science
Moderna Stock Soars as New Cancer Research Initiative Ignites Market Enthusiasm Oct 10, 2026 Life Science
Bristol Myers Squibb’s Zenbexus Posts Win in Phase 3 Trial, What It Means for Investors Oct 9, 2026 Life Science
UBS Analyst Is Bullish on Eli Lilly, but Novo Nordisk Is Not Necessarily a Value Trap Oct 8, 2026 Life Science
Barclays Initiates Coverage of the U.S. Medical Technology Sector and Says Valuations Have Reached a Ten-Year Low Oct 7, 2026 Life Science
Option Care Health Receives $5.8 Billion Acquisition Offer, Stock Price Soars 33% in a Single Day Oct 7, 2026 Life Science
Pfizer’s High Dividend Is Undervalued by the Market, and Investors May Be Facing a Good Opportunity to Position Themselves Oct 6, 2026 Life Science
Down 70%, Novo Nordisk Bets $3.9 Billion to Outrun Eli Lilly in the Weight-Loss Race Oct 2, 2026 Life Science
Johnson & Johnson Maintains Steady Dividends While Eli Lilly Bets on the Weight-Loss Drug Track Oct 2, 2026 Life Science
